Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners

Publication date: Dec 04, 2024

Monitoring the zoonotic potential of emerging SARS-CoV-2 variants in animals is a critical tool to protect public health. We conducted a longitudinal study in 47 households reporting people with COVID-19 in Texas in January-July 2022, during the first Omicron wave. We evaluated 105 people and 100 of their companion animals by RT-qPCR for SARS-CoV-2 at three sequential sampling events 1-2 weeks apart, starting 0-5 days after the first reported diagnosis of COVID-19 in the house. Of 47 households that reported people with COVID-19, SARS-CoV-2 was detected in 43, with 68% of people testing positive by RT-qPCR; 95.5% of people had antibodies to SARS-CoV-2. Dogs were the only animal species positive by RT-qPCR (5.4%; 3/55). Viral copies were consistently lower in dogs than household members, and no infectious virus was recovered in cell culture. Whole genome sequencing revealed household clusters of Omicron subvariants BA.1.1, BA.2.3.4 and BA.5.1.1 in people, dogs and a food bowl, confirming human-to-dog transmission within households, with no evidence of onward transmission from the infected dogs. Eleven dogs (n = 55) and two cats (n = 26) had neutralizing antibodies against SARS-CoV-2. Infection was not associated with clinical signs in pets; only two animals that tested negative for SARS-CoV-2 were reported to be sick. Nearly one-third (30.2%) of households with active COVID-19 had pets exposed to SARS-CoV-2, similar to our pre-Omicron studies, yet incidence of infection in cats was lower compared to pre-Omicron. These differences suggest that the zoonotic transmission dynamics in households may differ based on variant.

PDF

Concepts Keywords
Arizona Cats
Epi_isl_18065570 Copyright
July Cov
Syringe Dogs
Zoonosis Household
Households
Infected
License
Medrxiv
Omicron
Pets
Positive
Preprint
Sampling
Sars

Semantics

Type Source Name
disease MESH COVID-19
disease IDO cell
disease MESH Infection
drug DRUGBANK Coenzyme M
disease IDO zoonosis
disease MESH Severe acute respiratory syndrome
disease IDO susceptibility
disease IDO host
disease IDO infection prevalence
disease IDO assay
drug DRUGBANK Water
drug DRUGBANK Serine
disease IDO blood
disease MESH persistent infections
disease MESH Reinfections
disease MESH seroconversion
disease IDO history
drug DRUGBANK Medical air
drug DRUGBANK Cefaclor
drug DRUGBANK Tropicamide
drug DRUGBANK Aspartame

Download Document

(Visited 1 times, 1 visits today)